•  
  •  
  •  
  •  

2025-10-08 04:01:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • koes
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange

Keywords Selected:  GrindwellNorton

Stock Report

  • Grindwell Norton Ltd posts Rs. 94.45 crores consolidated PAT in Q1 FY2026
  • Grindwell Norton Ltd posts Rs. 93.18 crores consolidated PAT in Q1 FY2024-25
  • Grindwell Norton Limited recommends dividend of Rs. 17
  • Grindwell Norton Ltd consolidated Q4 FY2024 net profit at Rs. 92.61 crores
  • Grindwell Norton Ltd Q3 FY24 consolidated profit slips QoQ to Rs. 92.16 crores
  • Grindwell Norton Ltd to invest in Advanced Synthetic Minerals Pvt Ltd
  • Grindwell Norton Limited to sell 49% in SG Shinagawa Refractories India Pvt Ltd
  • Grindwell Norton Ltd Q1 FY24 consolidated PAT slips QoQ to Rs. 96.99 crores
  • Grindwell Norton Limited recommends dividend of Rs. 14.50
  • Grindwell Norton Ltd reports consolidated PAT of Rs. 99.23 crores in Q4 FY23
  • Grindwell Norton Ltd Q3 FY2023 consolidated profit at Rs. 80.19 crores
  • Norton Abrasives inaugurates its Paper Maker Plant in Bengaluru to manufacture paper based abrasive products
  • Grindwell Norton Ltd consolidated Q2FY23 net profit at Rs. 90.06 crores
  • Grindwell Norton Ltd consolidated Q1FY23 PAT up at Rs. 92.43 crores
  • Grindwell Norton Limited to acquire PRS Permacel Pvt Ltd
  • Grindwell Norton Limited recommends dividend of Rs. 12
  • Grindwell Norton posts rise in Q4FY22 consolidated PAT to Rs. 89.72 crores
  • Grindwell Norton Q3FY22 consolidated PAT at Rs. 69.70 crores
  • Grindwell Norton Ltd consolidated Q2 FY22 profit higher at Rs. 72 crore

Latest Post

  • koes
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024